Riskpilot← Back to searchSign inGet full accessIngarödoktorn AB
ABActiveOrg 5566131990Näsdalsplatån 5Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20010 employees
Revenue 2025
SEK 0
EBITDA margin
—
-101% vs 2024
Equity ratio
66.3%
Financial strength
Net profit 2025
SEK -9K
-101% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -23K | -101% |
| Net profit | SEK -9K | -101% |
| Total assets | SEK 7M | -11% |
| Equity | SEK 4,6M | -5% |
| Employees | 0 | — |
Legal name
Ingarödoktorn AB
Org number
5566131990
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
8 augusti 2001
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolagets verksamhet ska vara av medicinsk inriktning. Konsulttjänster inom hälso och sjukvårdsområdet samt läkarverksamhet.
Address
Näsdalsplatån 5
Email
dan.kornfeld5@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 430 | 2 229 | 3 610 | 3 103 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 325 | 2 101 | 3 475 | 2 981 | −23 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 325 | 2 101 | 3 475 | 2 981 | −23 |
| Net financials | — | −1 | 32 | 111 | 26 |
| Profit before tax | 324 | 1 567 | 2 621 | 2 303 | 3 |
| Tax | −70 | −330 | −548 | −488 | −13 |
| Net profit | 254 | 1 237 | 2 073 | 1 815 | −9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 533 | 2 410 | 5 559 | 7 812 | 6 986 |
| Equity | 355 | 1 362 | 3 240 | 4 850 | 4 631 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 178 | 514 | 900 | 753 | 147 |
| Total debt | 178 | 514 | 900 | 753 | 147 |
EBITDA margin
-2338500.0%
This company
15.8%
Market median
-14800733% vs market
20212025
Equity ratio
66.3%
This company
38.2%
Market median
+74% vs market
20212025
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20212025
Net profit margin
-948200.0%
This company
8.1%
Market median
-11706273% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DD Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ingarödoktorn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Dariusz Kornfeld | Chief Executive Officer | 0 companies |
| Anne-Charlotte Kornfeld | Chief Executive Officer | 0 companies |
| Rebecka Charlotte Kornfeld | Deputy Board Member | 0 companies |